
Medigus Ltd. MDGS
Geschäftsbericht 2024
hinzugefügt 11.04.2026
Land |
|
IPO-Jahr |
- |
Branche |
Medizinische Geräte |
Börse |
NASDAQ GLOBAL |
Anteile |
- |
Marktkapitalisierung |
$ 55.5 M |
EBITDA (LTM) |
$ -2.47 M |
P/E (LTM) |
- |
P/S (LTM) |
407.79 |
EPS (LTM) |
- |
Andere Aktien der Branche "Medizinische Geräte"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
$ 186.7 | 1.09 % | $ 14 B | Nasdaq Global Select Market,SPB | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
AdaptHealth Corp.
AHCO
|
$ 12.75 | -0.16 % | $ 1.72 B | Nasdaq Capital Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Bio-Rad Laboratories
BIO
|
$ 297.06 | 1.65 % | $ 8.38 B | NYSE,SPB | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
EDAP TMS S.A.
EDAP
|
$ 3.38 | 0.3 % | $ 127 M | Nasdaq Global Market | ||
|
Bruker Corporation
BRKR
|
$ 40.55 | 1.62 % | $ 6.04 K | Nasdaq Global Select Market,SPB | ||
|
Boston Scientific Corporation
BSX
|
$ 64.42 | 0.96 % | $ 95.4 B | NYSE,SPB | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.6 | 1.04 % | $ 37.3 M | Nasdaq Capital Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
Helius Medical Technologies
HSDT
|
$ 1.99 | 0.25 % | $ 1.21 M | Nasdaq Capital Market | ||
|
ClearPoint Neuro
CLPT
|
$ 10.52 | 1.34 % | $ 298 M | Nasdaq Capital Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
Electromed
ELMD
|
$ 25.75 | 2.14 % | $ 218 M | NYSE American | ||
|
Inogen
INGN
|
$ 6.32 | -0.39 % | $ 168 M | Nasdaq Global Select Market,SPB | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
IRIDEX Corporation
IRIX
|
$ 1.02 | -0.97 % | $ 17.3 M | Nasdaq Global Select Market | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
LENSAR
LNSR
|
$ 6.18 | 2.29 % | $ 73.9 M | Nasdaq Capital Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
Globus Medical
GMED
|
$ 94.74 | -0.19 % | $ 12.8 B | NYSE,SPB | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 18.28 | 2.35 % | $ 429 M | Nasdaq Global Select Market,SPB | ||
|
Butterfly Network
BFLY
|
$ 4.79 | 8.14 % | $ 1.01 B | NYSE | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
Myomo
MYO
|
$ 0.8 | 2.8 % | $ 33.5 M | NYSE American | ||
|
Delcath Systems
DCTH
|
$ 10.91 | 0.28 % | $ 391 M | Nasdaq Capital Market | ||
|
Inspire Medical Systems
INSP
|
$ 57.67 | 1.42 % | $ 1.69 B | NYSE,SPB | ||
|
CONMED Corporation
CNMD
|
$ 39.45 | -0.73 % | $ 1.22 B | NYSE,SPB | ||
|
LivaNova PLC
LIVN
|
$ 65.54 | 0.85 % | $ 3.58 B | Nasdaq Global Select Market | ||
|
Integer Holdings Corporation
ITGR
|
$ 87.73 | -1.0 % | $ 3.05 B | NYSE,SPB | ||
|
FONAR Corporation
FONR
|
$ 18.75 | -0.05 % | $ 123 M | Nasdaq Capital Market | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | ||
|
Edwards Lifesciences Corporation
EW
|
$ 77.64 | -0.71 % | $ 45.4 B | NYSE,SPB | ||
|
NanoVibronix
NAOV
|
- | - | $ 1.08 M | Nasdaq Global Select Market |